AUSTIN, Texas--(BUSINESS WIRE)--October 30, 2025-- 

Natera, Inc. $(NTRA)$, a global leader in cell-free DNA and precision medicine, today announced that it will release results for its third quarter ended September 30, 2025, after the market closes on November 6, 2025. Natera will host a conference call and webcast shortly thereafter at 4:30 p.m. ET.

 
Earnings Conference Call Information 
Event:            Natera's Third Quarter 2025 Financial Results 
Date:             November 6, 2025 
Time:             4:30 p.m. ET 
Live Dial-In:     1-888-770-7321 (Domestic) 
                  1-929-201-7107 (International) 
Conference ID:    7684785 
Webcast:          https://events.q4inc.com/attendee/822764987 
 

A webcast replay will be available at investor.natera.com.

About Natera

Natera$(TM)$ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments $(CLIA)$ in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251030336447/en/

 
    CONTACT:    Investor Relations: Mike Brophy, CFO, Natera, Inc., investor@natera.com 

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

(END) Dow Jones Newswires

October 30, 2025 07:06 ET (11:06 GMT)